Riskpilot← Back to searchSign inGet full accessSleep Cure AB
ABActiveOrg 5591209738GöteborgComputer programming activities · NACE 6210Est. 20171 employees
Revenue 2024
SEK 0
EBITDA margin
—
-200% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -1K
-206% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | -200% |
| Net profit | SEK -1K | -206% |
| Total assets | SEK 84K | -1% |
| Equity | SEK 84K | -1% |
| Employees | 1 | — |
Legal name
Sleep Cure AB
Org number
5591209738
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
3 augusti 2017
Share capital
SEK 83 300
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utveckla, marknadsföra och sälja mjukvara och därmed förenlig verksamhet.
Address
Göteborg
Email
martin.lindau@madinsweden.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 | 24 | 73 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −586 | −5 | 1 837 | 1 | −1 |
| Depreciation & amort. | −0 | −0 | −1 919 | — | — |
| EBIT | −586 | −5 | −82 | 1 | −1 |
| Net financials | −84 | −111 | −0 | −0 | — |
| Profit before tax | −670 | −116 | −82 | 1 | −1 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −670 | −116 | −82 | 1 | −1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 220 | 2 005 | 99 | 85 | 84 |
| Equity | 282 | 166 | 84 | 85 | 84 |
| Long-term debt | 1 449 | 1 449 | 0 | — | — |
| Short-term debt | 490 | 391 | 16 | 0 | — |
| Total debt | 1 939 | 1 840 | 16 | — | — |
EBITDA margin
-120000.0%
This company
15.8%
Market median
-759594% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20202024
Net profit margin
-120000.0%
This company
8.1%
Market median
-1481581% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sleep Cure AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Henrik Lindau | Chairman | 0 companies |
| Peter Martin Clint Kurzwelly | Board of Directors | 0 companies |
| Leif Patrik Aronsson | Board of Directors | 0 companies |